ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628690 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628690; 2) Community: the network communities that were significantly associated with the response to NSC 628690; 3) Molecule: the relationships between components within communities and NSC 628690; 4) MDR: the compounds that were significantly associated with the NSC 628690.

NSC Compound Enrichment Correlation
NSC 745617 Null 0.00306027196853058 -0.31087844
NSC 688303 Null 0.00311751113090895 -0.012507109
NSC 722508 2-(4-ethylpiperazinyl)3-p-methoxybenzoyl quinoxaline 0.00311751113090895 0.02425576
NSC 743507 Null 0.00311751113090895 0.34506114
NSC 643915 Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- 0.00385572727186 0.32405206
NSC 119875 Cisplatin 0.00396220821750028 0.10251111
NSC 361887 1H-Purine-2,6-dione, 8-[3-(dimethylamino)propoxy]-3,7- dihydro-1,3,7-trimethyl-, mixt. with 1,7-dihydro-6H- purine-6-thione 0.00396220821750028 0.13441449
NSC 628591 Null 0.00396220821750028 0.30050496
NSC 694002 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.00418964244951812 0.29131574
NSC 714685 Null 0.00418964244951812 0.28284017
Total:36  Current:2    [First] [Prev] [Next] [Last]